Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Millipore expands kinase line to widest worldwide

Millipore expands kinase line to widest worldwide

22nd November 2007

Millipore has confirmed that it is to expand its PI3 kinase line, making it the broadest panel of lipid kinases across the globe.

Available both for purchase and as part of its gold-standard KinaseProfiler service, the firm now has 17 lipid kinases on offer, more than any other company.

"Lipid kinases are one of the most promising new classes of potential drug targets," explained a spokesperson for the life science company.

"PI3 kinases regulate a wide variety of cellular functions, including cell growth, proliferation, differentiation, motility, survival and intracellular trafficking," the representative continued.

Defects in PI3 kinase function lead to numerous disease states, including several forms of cancer, while Millipore’s lipid kinase panel and KinaseProfiler service dissect the networks underlying PI3 kinase signalling – essential for the design of new therapies.

Established in 1954, Millipore’s target-profiling services, multiplex and traditional immunoassays and clinical lab contract services aim to help customers prioritise potential drug candidates, screen numerous biomarkers simultaneously and conduct research and clinical studies. ADNFCR-1050-ID-18365339-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.